Printer Friendly

MARION MERRELL DOW COMPLETES ACQUISITION OF HENNING BERLIN GMBH

 MARION MERRELL DOW COMPLETES ACQUISITION OF HENNING BERLIN GMBH
 KANSAS CITY, Mo., Jan. 2 /PRNewswire/ -- Marion Merrell Dow Inc. (NYSE: MKC) today announced it has completed the previously disclosed acquisition of Henning Berlin GmbH, a closely held German pharmaceutical company headquartered in Berlin.
 The transaction to acquire Henning Berlin closed after the two companies received the necessary approvals from German regulatory agencies. The financial terms of the acquisition were not disclosed.
 Henning Berlin GmbH is involved in the development, manufacture, marketing and sale of a line of products for the treatment of thyroid disorders and associated diagnostic tests. The company's other product lines include therapies for the treatment of osteoporosis, cardiovascular disorders and inflammatory bowel diseases.
 Headquartered in Kansas City, Marion Merrell Dow is involved in the discovery, development, manufacture and marketing of prescription and over-the-counter pharmaceutical products in North America, Europe and the Pacific Basin.
 -0- 1/2/91
 /CONTACT: Larry W. Wheeler or David M. Thompson both of Marion Merrell Dow, 816-966-4000/
 (MKC) CO: Marion Merrell Dow Inc.; Henning Berlin GmbH ST: Missouri IN: SU: TNM


MC -- DV006 -- 6295 01/02/92 16:56 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 2, 1992
Words:187
Previous Article:ADVANCED GRAVIS COMPUTER TECHNOLOGY LTD. REPORTS NINE-MONTH OPERATING RESULTS
Next Article:/ C O R R E C T I O N -- CHRYSLER CORPORATION /
Topics:


Related Articles
MARION MERRELL DOW ACQUIRES GERMAN PHARMACEUTICAL COMPANY
MARION MERRELL DOW ACQUIRES GENERIC DRUG BUSINESS OF RUGBY-DARBY GROUP COMPANIES
MARION MERRELL DOW COMPLETES ACQUISITION OF AMERICA'S LARGEST GENERIC DRUG COMPANY
MARION MERRELL DOW INC. INCREASES ITS OWNERSHIP IN JAPAN'S KODAMA LTD.
MARION MERRELL DOW INC. COMPLETES ACQUISITION OF SELECTIDE CORP. TO ACCELERATE DRUG DISCOVERY
HOECHST, MARION MERRELL DOW AND DOW CHEMICAL MAKE JOINT ANNOUNCEMENT
COMPANIES ANNOUNCE DISCUSSIONS ON POSSIBLE ACQUISITION OF MARION MERRELL DOW INC.
COMPANIES ANNOUNCE DEFINITIVE AGREEMENTS FOR HOECHST TO ACQUIRE MARION MERRELL DOW
MARION MERRELL DOW INC. ANNOUNCES REQUEST FROM FTC FOR ADDITIONAL INFORMATION ON PROPOSED ACQUISITION
HOECHST AG COMPLETES ACQUISITION OF MARION MERRELL DOW INC. - A STEP TOWARD GLOBAL LEADERSHIP IN PHARMACEUTICALS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters